Multiple Sclerosis International Federation

Recent papers from Multiple Sclerosis International Federation

1. Impact of multiple sclerosis symptoms survey: Patient-reported data on the prevalence, burden, and management of multiple sclerosis symptoms in EuropeMultiple Sclerosis Journal · 2026
2. Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MSMultiple Sclerosis Journal · 2026
3. A Scoring System for the Assessment of Quality of Care in the Management of Transfusion Dependent ThalassemiaHematology Reports · 2026
4. Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS projectAnnals of the Rheumatic Diseases · 2026
5. Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald CriteriaNeurology Clinical Practice · 2026
6. Minimally acceptable criteria and required sample size for an accuracy study of non-invasive prenatal testing of sickle cell disease in screen positive women in England: results of a decision tree modelDiagnostic and Prognostic Research · 2026
7. Modelling the cost-effectiveness of non-invasive prenatal testing in the English sickle cell and thalassaemia screening pathwayDiagnostic and Prognostic Research · 2026
8. Unstable Hemoglobin Variants: Molecular Mechanisms, Clinical Phenotypes, and a Practical Diagnostic and Management ApproachHemoglobin · 2026
9. Effectiveness of disease management across healthcare settings: the Multiple Sclerosis Center is a pillar for multi-disciplinary practices that promote quality of life for people with Multiple SclerosisSHILAP Revista de lepidopterología · 2026
10. The Use of Patient-Reported Outcome Measures in Developmental Age: A Complementary Tool for Pediatric Multiple Sclerosis PrognosisNeurology and Therapy · 2026
11. Multiple sclerosis expert patient program in Central America: changes in quality of life and lifestyle habitsNeurodegenerative Disease Management · 2025
12. Rheumatologist and patient perspectives on axial spondyloarthritis management and treatment satisfaction in EuropeSeminars in Arthritis and Rheumatism · 2025
13. First attempt to identify and prioritise best beekeeping practices with a multi-actor approach in the EUJournal of Apicultural Research · 2025
14. The disease burden of β-thalassaemia revisitedHematology · 2025
15. Impact of Working From Home on the Psychological Well‐Being of 365 European Patients With Rheumatic Diseases During COVID‐19 Pandemic. Results of the REUMAVID StudyMusculoskeletal Care · 2025
16. Brain health – time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 reportMultiple Sclerosis and Related Disorders · 2025
17. Artificial intelligence and science of patient input: a perspective from people with multiple sclerosisFrontiers in Immunology · 2025
18. The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial SpondyloarthritisAnnals of the Rheumatic Diseases · 2025
19. Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, third editionJournal of Neurology Neurosurgery & Psychiatry · 2025
20. Females With Axial Spondyloarthritis Have Longer Diagnostic Delay and Higher Burden of the Disease. Results From the International Map of Axial Spondyloarthritis ( IMAS )International Journal of Rheumatic Diseases · 2024